NHS England has today (28 January 2016) launched a 30 day public consultation on a proposed number of new products for specialised services, (including service specifications and clinical commissioning policies). There has already been extensive engagement on these national specifications and policies, as they have been developed with the support and input of lead clinicans and patient and public representatives. This approach has helped ensure that the views of key stakeholders have informed and influenced the development of the specifications and policies to date. Please note this is one of several public consultations on a proposed number of new draft products for specialised services. We now wish to test them further with wider groups of stakeholders.
Liver Transplantation Service (Adults)
Dornase alfa inhaled therapy for primary ciliary dyskinesia (all ages)
Pasireotide: An injectable medical therapy for the treatment of Cushing's disease
Personalised External Aortic Root Support (PEARS) for surgical management of enlarged aortic root (adults)
Robotic assisted trans-oral surgery
Rituximab for CIPD
Temperature-controlled laminar airflow device
Palliative radiotherapy for bone cancer
Radiotherapy for breast cancer
Share
Share on Twitter Share on Facebook